| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.006 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.007 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |